NKF K/DOQI GUIDELINES
| |
NKF K/DOQI GUIDELINES
|
REFERENCES
1. Sarnak MJ, Levey AS: “Epidemiology of Cardiac Disease” in Dialysis Patients: Uremia-Related Risk Factors. Seminars in Dialysis 12:69-76, 1999
2. U.S. Renal Data System: USRDS 2002 Annual Data Report, in, Bethesda, MD, The National Institutes of Health, National Institute of Diabetes and Digestive Diseases, 2002
3. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, Held PJ, Port FK: Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 341:1725-1730, 1999
4. Bonal J, Cleries M, Vela E: Transplantation versus haemodialysis in elderly patients. Renal Registry Committee. Nephrol Dial Transplant 12:261-264, 1997
5. Lindner A, Charra B, Sherrard DJ, Scribner BH: Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 290:697-701, 1974
6. Rostand SG, Gretes JC, Kirk KA, Rutsky EA, Andreoli TE: Ischemic heart disease in patients with uremia undergoing maintenance hemodialysis. Kidney Int 16:600-611, 1979
7. Herzog CA, Ma JZ, Collins AJ: Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med 339:799-805, 1998
8. Beattie JN, Soman SS, Sandberg KR, Yee J, Borzak S, Garg M, McCullough PA: Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction. Am J Kidney Dis 37:1191-1200, 2001
9. Ansari A, Kaupke CJ, Vaziri ND, Miller R, Barbari A: Cardiac pathology in patients with end-stage renal disease maintained on hemodialysis. Int J Artif Organs 16:31-36, 1993
10. Hida M, Saitoh H, Satoh T: Autopsy findings in diabetic nephropathy patients under dialysis, collected from the annuals of pathological autopsy cases in Japan. Tokai J Exp Clin Med 9:357-362, 1984
11. Schwarz U, Buzello M, Ritz E, Stein G, Raabe G, Wiest G, Mall G, Amann K: Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol Dial Transplant 15:218-223, 2000
12. Clyne N, Lins LE, Pehrsson SK: Occurrence and significance of heart disease in uraemia. An autopsy study. Scand J Urol Nephrol 20:307-311, 1986
13. Bleyer AJ, Russell GB, Satko SG: Sudden and cardiac death rates in hemodialysis patients. Kidney Int 55:1553-1559, 1999
14. Parekh RS, Carroll CE, Wolfe RA, Port FK: Cardiovascular mortality in children and young adults with end-stage kidney disease. J Pediatr 141:191-197, 2002
15. Chavers BM, Li S, Collins AJ, Herzog CA: Cardiovascular disease in pediatric chronic dialysis patients. Kidney Int 62:648-653, 2002
16. Groothoff JW, Gruppen MP, Offringa M, Hutten J, Lilien MR, Van De Kar NJ, Wolff ED, Davin JC, Heymans HS: Mortality and causes of death of end-stage renal disease in children: a Dutch cohort study. Kidney Int 61:621-629, 2002
17. U.S. Renal Data System: USRDS 2003 Annual Data Report, in, Bethesda, MD, The National Institutes of Health, National Institute of Diabetes and Digestive Diseases, 2003
18. Anderson RN, Smith BL: Deaths: leading causes for 2001. Natl Vital Stat Rep 52:1-85, 2003
19. Neu AM, Ho PL, McDonald RA, Warady BA: Chronic dialysis in children and adolescents. The 2001 NAPRTCS Annual Report. Pediatr Nephrol 17:656-663, 2002
20. Honda M: The 1997 Report of the Japanese National Registry data on pediatric peritoneal dialysis patients. Perit Dial Int 19:S473-478, 1999 (suppl 2)
21. Verrina E, Perfumo F, Calevo MG, Rinaldi S, Sorino P, Andreetta B, Bonaudo R, Lavoratti G, Edefonti A: The Italian Pediatric Chronic Peritoneal Dialysis Registry. Perit Dial Int 19:S479-483, 1999 (suppl 2)
22. Reiss U, Wingen AM, Scharer K: Mortality trends in pediatric patients with chronic renal failure. Pediatr Nephrol 10:41-45, 1996
23. Hisano S, Tsuru N, Itoh Y, Hattori S, Uchiyama M, Tamanaha K, Ninomiya M, Furuse A, Yamagishi M, Hohjoh M, et al.: Epidemiologic survey of children with end-stage renal disease. Acta Paediatr Jpn 32:343-348, 1990
24. Ehrich JH, Rizzoni G, Brunner FP, Fassbinder W, Geerlings W, Mallick NP, Raine AE, Selwood NH, Tufveson G: Renal replacement therapy for end-stage renal failure before 2 years of age. Nephrol Dial Transplant 7:1171-1177, 1992
25. Bosch A, Ulmer HE, Keller HE, Bonzel KE, Scharer K: Electrocardiographic monitoring in children with chronic renal failure. Pediatr Nephrol 4:140-144, 1990
26. Butani L, Berg G, Makker SP: QTc interval in children with chronic renal failure and with renal transplants. Pediatr Nephrol 17:6-9, 2002
27. Kocak G, Atalay S, Bakkaloglu S, Ekim M, Tutar HE, Imamoglu A: QT/corrected QT (QTc) intervals and QT/QTc dispersions in children with chronic renal failure. Int J Cardiol 70:63-67, 1999
28. Valsangiacomo E, Neuhaus TJ, Goetschel P, Bauersfeld U: Cardiac rhythm disturbances in children on hemodialysis. Pediatr Nephrol 17:837-841, 2002
29. Nayir A, Bilge I, Kilicaslan I, Ander H, Emre S, Sirin A: Arterial changes in paediatric haemodialysis patients undergoing renal transplantation. Nephrol Dial Transplant 16:2041-2047, 2001
30. Pennisi AJ, Heuser ET, Mickey MR, Lipsey A, Malekzadeh MH, Fine RN: Hyperlipidemia in pediatric hemodialysis and renal transplant patients. Associated with coronary artery disease. Am J Dis Child 130:957-961, 1976
31. Eifinger F, Wahn F, Querfeld U, Pollok M, Gevargez A, Kriener P, Gronemeyer D: Coronary artery calcifications in children and young adults treated with renal replacement therapy. Nephrol Dial Transplant 15:1892-1894, 2000
32. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB: Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342:1478-1483, 2000
33. Milliner DS, Zinsmeister AR, Lieberman E, Landing B: Soft tissue calcification in pediatric patients with end-stage renal disease. Kidney Int 38:931-936, 1990
34. Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U, Mehls O, Schaefer F: Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106:100-105, 2002
35. Gruppen MP, Groothoff JW, Prins M, van der Wouw P, Offringa M, Bos WJ, Davin JC, Heymans HS: Cardiac disease in young adult patients with end-stage renal disease since childhood: a Dutch cohort study. Kidney Int 63:1058-1065, 2003
36. Litwin M, Grenda R, Prokurat S, Abuauba M, Latoszynska J, Jobs K, Boguszewska-Baczkowska A, Wawer ZT: Patient survival and causes of death on hemodialysis and peritoneal dialysis–single-center study. Pediatr Nephrol 16:996-1001, 2001
37. Mitsnefes MM, Kimball TR, Witt SA, Glascock BJ, Khoury PR, Daniels SR: Left ventricular mass and systolic performance in pediatric patients with chronic renal failure. Circulation 107:864-868, 2003
38. NAPRTCS Annual Report 2001, in, Boston, MA, North American Pediatric Renal Transplant Cooperative Study Administrative Office, 2001, pp Part 3: Sec. 8-13
39. Aksu N, Yavascan O, Erdogan H, Dorak MC, Kansoy S, Kozan M: Echocardiographic evaluation in children treated with CAPD. Adv Perit Dial 14:255-257, 1998
40. Mitsnefes MM, Daniels SR, Schwartz SM, Meyer RA, Khoury P, Strife CF: Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors. Pediatr Nephrol 14:898-902, 2000
41. Atalay S, Ekim M, Tutar HE, Kocak G, Bakkaloglu S, Tumer N: Systolic and diastolic function in children with chronic renal failure. Pediatr Int 44:18-23, 2002
42. Mitsnefes MM, Daniels SR, Schwartz SM, Khoury P, Strife CF: Changes in left ventricular mass in children and adolescents during chronic dialysis. Pediatr Nephrol 16:318-323, 2001
43. Rivenes SM, Colan SD, Easley KA, Kaplan S, Jenkins KJ, Khan MN, Lai WW, Lipshultz SE, Moodie DS, Starc TJ, Sopko G, Zhang W, Bricker JT: Usefulness of the pediatric electrocardiogram in detecting left ventricular hypertrophy: results from the Prospective Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2 HIV) multicenter study. Am Heart J 145:716-723, 2003
44. Fogel MA, Lieb DR, Seliem MA: Validity of electrocardiographic criteria for left ventricular hypertrophy in children with pressure- or volume-loaded ventricles: comparison with echocardiographic left ventricular muscle mass. Pediatr Cardiol 16:261-269, 1995
45. Bonow RO, Carabello B, de Leon AC, Edmunds LH, Jr., Fedderly BJ, Freed MD, Gaasch WH, McKay CR, Nishimura RA, O’Gara PT, O’Rourke RA, Rahimtoola SH, Ritchie JL, Cheitlin MD, Eagle KA, Gardner TJ, Garson A, Jr., Gibbons RJ, Russell RO, Ryan TJ, Smith SC, Jr.: ACC/AHA Guidelines for the Management of Patients With Valvular Heart Disease. Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease). J Heart Valve Dis 7:672-707, 1998
46. Cecchin F, Jorgenson DB, Berul CI, Perry JC, Zimmerman AA, Duncan BW, Lupinetti FM, Snyder D, Lyster td, Rosenthal GL, Cross B, Atkins DL: Is arrhythmia detection by automatic external defibrillator accurate for children? sensitivity and specificity of an automatic external defibrillator algorithm in 696 pediatric arrhythmias. Circulation 103:2483-2488, 2001
47. Atkins DL, Hartley LL, York DK: Accurate recognition and effective treatment of ventricular fibrillation by automated external defibrillators in adolescents. Pediatrics 101:393-397, 1998
48. Samson R, Berg R, Bingham R: Use of automated external defibrillators for children: an update. An advisory statement from the Pediatric Advanced Life Support Task Force, International Liaison Committee on Resuscitation. Resuscitation 57:237-243, 2003
49. Standards of medical care in diabetes. Diabetes Care 27 Suppl 1:S15-35, 2004
50. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555-576, 2004
51. K/DOQI Clinical Practice Guidelines for Managing Dyslipidemias in Chronic Kidney Disease. Am J Kidney Dis 41:S1-S92, 2003 (suppl 3)
52. NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure. National Kidney Foundation-Dialysis Outcomes Quality Initiative. Am J Kidney Dis 30:S192-240, 1997 (suppl 3)
53. Gaston RS, Danovitch GM, Adams PL, Wynn JJ, Merion RM, Deierhoi MH, Metzger RA, Cecka JM, Harmon WE, Leichtman AB, Spital A, Blumberg E, Herzog CA, Wolfe RA, Tyan DB, Roberts J, Rohrer R, Port FK, Delmonico FL: The report of a national conference on the wait list for kidney transplantation. Am J Transplant 3:775-785, 2003
54. U.S. Renal Data System: USRDS 2001 Annual Data Report, in, Bethesda, MD, The National Institutes of Health, National Institute of Diabetes and Digestive Diseases, 2001
55. Herzog CA: How to manage the renal patient with coronary heart disease: the agony and the ecstasy of opinion-based medicine. J Am Soc Nephrol 14:2556-2572, 2003
56. Herzog CA, Marwick TH, Pheley AM, White CW, Rao VK, Dick CD: Dobutamine stress echocardiography for the detection of significant coronary artery disease in renal transplant candidates. Am J Kidney Dis 33:1080-1090, 1999
57. Dahan M, Viron BM, Faraggi M, Himbert DL, Lagallicier BJ, Kolta AM, Pessione F, Le Guludec D, Gourgon R, Mignon FE: Diagnostic accuracy and prognostic value of combined dipyridamole-exercise thallium imaging in hemodialysis patients. Kidney Int 54:255-262, 1998
58. Rabbat CG, Treleaven DJ, Russell JD, Ludwin D, Cook DJ: Prognostic value of myocardial perfusion studies in patients with end-stage renal disease assessed for kidney or kidney-pancreas transplantation: a meta-analysis. J Am Soc Nephrol 14:431-439, 2003
59. Wright RS, Reeder GS, Herzog CA, Albright RC, Williams BA, Dvorak DL, Miller WL, Murphy JG, Kopecky SL, Jaffe AS: Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med 137:563-570, 2002
60. Shlipak MG, Heidenreich PA, Noguchi H, Chertow GM, Browner WS, McClellan MB: Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med 137:555-562, 2002
61. McCullough PA, Sandberg KR, Borzak S, Hudson MP, Garg M, Manley HJ: Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease. Am Heart J 144:226-232, 2002
62. Jeremias A, Bhatt DL, Chew DP, Ziada KM, Albirini A, Brener SJ, Lincoff AM, Topol EJ, Ellis SG: Safety of abciximab during percutaneous coronary intervention in patients with chronic renal insufficiency. Am J Cardiol 89:1209-1211, 2002
63. Best PJ, Lennon R, Gersh BJ, Ting HH, Rihal CS, Bell MR, Herzog CA, Holmes DR, Jr., Berger PB: Safety of abciximab in patients with chronic renal insufficiency who are undergoing percutaneous coronary interventions. Am Heart J 146:345-350, 2003
64. Frilling B, Zahn R, Fraiture B, Mark B, Donges K, Becker T, Siegler KE, Seidl K, Rustige J, Senges J: Comparison of efficacy and complication rates after percutaneous coronary interventions in patients with and without renal insufficiency treated with abciximab. Am J Cardiol 89:450-452, 2002
65. Freeman RV, Mehta RH, Al Badr W, Cooper JV, Kline-Rogers E, Eagle KA: Influence of concurrent renal dysfunction on outcomes of patients with acute coronary syndromes and implications of the use of glycoprotein IIb/IIIa inhibitors. J Am Coll Cardiol 41:718-724, 2003
66. Kaufman JS, O’Connor TZ, Zhang JH, Cronin RE, Fiore LD, Ganz MB, Goldfarb DS, Peduzzi PN: Randomized controlled trial of clopidogrel plus aspirin to prevent hemodialysis access graft thrombosis. J Am Soc Nephrol 14:2313-2321, 2003
67. Herzog CA, Ma JZ, Collins AJ: Comparative Survival of Dialysis Patients in the United States After Coronary Angioplasty, Coronary Artery Stenting, and Coronary Artery Bypass Surgery and Impact of Diabetes. Circulation 106:2207-2211, 2002
68. Herzog CA, Ma JZ, Collins AJ: Long-term outcome of dialysis patients in the United States with coronary revascularization procedures. Kidney Int 56:324-332, 1999
69. Szczech LA, Reddan DN, Owen WF, Califf R, Racz M, Jones RH, Hannan EL: Differential survival after coronary revascularization procedures among patients with renal insufficiency. Kidney Int 60:292-299, 2001
70. Herzog CA, Ma JZ, Collins AJ: Long-term survival of dialysis patients in the United States with prosthetic heart valves: should ACC/AHA practice guidelines on valve selection be modified? Circulation 105:1336-1341, 2002
71. Azar RR, Prpic R, Ho KK, Kiernan FJ, Shubrooks SJ, Jr., Baim DS, Popma JJ, Kuntz RE, Cohen DJ: Impact of end-stage renal disease on clinical and angiographic outcomes after coronary stenting. Am J Cardiol 86:485-489, 2000
72. Hase H, Nakamura M, Joki N, Tsunoda T, Nakamura R, Saijyo T, Morishita M, Yamaguchi T: Independent predictors of restenosis after percutaneous coronary revascularization in haemodialysis patients. Nephrol Dial Transplant 16:2372-2377, 2001
73. Rinehart AL, Herzog CA, Collins AJ, Flack JM, Ma JZ, Opsahl JA: A comparison of coronary angioplasty and coronary artery bypass grafting outcomes in chronic dialysis patients. Am J Kidney Dis 25:281-290, 1995
74. Agirbasli M, Weintraub WS, Chang GL, King SB, Guyton RA, Thompson td, Alameddine F, Ghazzal ZM: Outcome of coronary revascularization in patients on renal dialysis. Am J Cardiol 86:395-399, 2000
75. Koyanagi T, Nishida H, Kitamura M, Endo M, Koyanagi H, Kawaguchi M, Magosaki N, Sumiyoshi T, Hosoda S: Comparison of clinical outcomes of coronary artery bypass grafting and percutaneous transluminal coronary angioplasty in renal dialysis patients. Ann Thorac Surg 61:1793-1796, 1996
76. London GM, Pannier B, Marchais SJ, Guerin AP: Calcification of the aortic valve in the dialyzed patient. J Am Soc Nephrol 11:778-783, 2000
77. Urena P, Malergue MC, Goldfarb B: Evolutive aortic stenosis in HD patients: Analysis of risk factors. Nephrologie 20: 217-225, 1999
78. K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. Am J Kidney Dis 42:S1-S202, 2003 (suppl 3)
79. Wongpraparut N, Apiyasawat S, Crespo G, Yazdani K, Jacobs LE, Kotler MN: Determinants of progression of aortic stenosis in patients aged > or =40 years. Am J Cardiol 89:350-352, 2002
80. Palta S, Pai AM, Gill KS, Pai RG: New insights into the progression of aortic stenosis: implications for secondary prevention. Circulation 101:2497-2502, 2000
81. Chertow GM, Burke SK, Raggi P: Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 62:245-252, 2002
82. Kaplon RJ, Cosgrove DM, Gillinov AM, Lytle BW, Blackstone EH, Smedira NG: Cardiac valve replacement in patients on dialysis: influence of prosthesis on survival. Ann Thoracic Surg 70:438-441, 2000
83. Lucke JC, Samy RN, Atkins BZ, Silvestry SC, Douglas JM, Schwab SJ, Wolfe WG, Glower DD: Results of valve replacement with mechanical and biological prostheses in chronic renal dialysis patients. Ann Thoracic Surg 64:129-132, 1997
84. Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, Barre PE: Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 47:186-192, 1995
85. Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Parfrey PS: Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int 47:884-890, 1995
86. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray D, Barre PE: Outcome and risk factors of ischemic heart disease in chronic uremia. Kidney Int 49:1428-1434, 1996
87. Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Cataliotti A, Seminara G, Stancanelli B, Malatino LS: Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis. J Am Soc Nephrol 12:2768-2774, 2001
88. De Lima J, Vieira M, Abensur H, Krieger E: Baseline blood pressure and other variables influencing survival on haemodialysis of patients without overt cardiovascular disease. Nephrol Dial Transplant 16:793-797, 2001
89. Cice G, Ferrara L, Di Benedetto A, Russo PE, Marinelli G, Pavese F, Iacono A: Dilated cardiomyopathy in dialysis patients–beneficial effects of carvedilol: a double-blind, placebo-controlled trial. J Am Coll Cardiol 37:407-411, 2001
90. Cice G, Ferrara L, D’Andrea A, D’Isa S, Di Benedetto A, Cittadini A, Russo PE, Golino P, Calabro R: Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial. J Am Coll Cardiol 41:1438-1444, 2003
91. Robson R, Collins J, Johnson R, Kitching R, Searle M, Walker R, Douglas J, Leary J, Whalley G, Sharpe N, MacMahon S: Effects of simvastatin and enalapril on serum lipoprotein concentrations and left ventricular mass in patients on dialysis. The Perfect Study Collaborative Group. J Nephrol 10:33-40, 1997
92. Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME, London GM: Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. Hypertension 32:570-574, 1998
93. Herzog CA: Cardiac arrest in dialysis patients: approaches to alter an abysmal outcome. Kidney Int Suppl 84:S197-200, 2003
94. D’Elia JA, Weinrauch LA, Gleason RE, Hampton LA, Smith-Ossman S, Yoburn DC, Kaldany A, Healy RW, Leland OS, Jr.: Application of the ambulatory 24-hour electrocardiogram in the prediction of cardiac death in dialysis patients. Arch Intern Med 148:2381-2385, 1988
95. Karnik JA, Young BS, Lew NL, Herget M, Dubinsky C, Lazarus JM, Chertow GM: Cardiac arrest and sudden death in dialysis units. Kidney Int 60:350-357, 2001
96. Morrison G, Michelson EL, Brown S, Morganroth J: Mechanism and prevention of cardiac arrhythmias in chronic hemodialysis patients. Kidney Int 17:811-819, 1980
97. Munger MA, Ateshkadi A, Cheung AK, Flaharty KK, Stoddard GJ, Marshall EH: Cardiopulmonary events during hemodialysis: effects of dialysis membranes and dialysate buffers. Am J Kidney Dis 36:130-139, 2000
98. Stevens LA, Levin A: Anaemia, cardiovascular disease and kidney disease: integrating new knowledge in 2002. Curr Opin Nephrol Hypertens 12:133-138, 2003
99. Levin A: Anemia and left ventricular hypertrophy in chronic kidney disease populations: a review of the current state of knowledge. Kidney Int Suppl 80:35-38, 2002
100. Levin A, Thompson CR, Ethier J, Carlisle EJ, Tobe S, Mendelssohn D, Burgess E, Jindal K, Barrett B, Singer J, Djurdjev O: Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis 34:125-134, 1999
101. Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Stancanelli B, Cataliotti A, Malatino LS: Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression. Kidney Int 65:1492-1498, 2004
102. Multicentre, cross-sectional study of ventricular arrhythmias in chronically haemodialysed patients. Gruppo Emodialisi e Patologie Cardiovasculari. Lancet 2:305-309, 1988
103. Erem C, Kulan K, Tuncer C, Bostan M, Mocan Z, Komsuoglu B: Cardiac arrhythmias in patients on maintenance hemodialysis. Acta Cardiol 52:25-36, 1997
104. Meier P, Vogt P, Blanc E: Ventricular arrhythmias and sudden cardiac death in end-stage renal disease patients on chronic hemodialysis. Nephron 87:199-214, 2001
105. Narula AS, Jha V, Bali HK, Sakhuja V, Sapru RP: Cardiac arrhythmias and silent myocardial ischemia during hemodialysis. Ren Fail 22:355-368, 2000
106. Ansari N, Manis T, Feinfeld DA: Symptomatic atrial arrhythmias in hemodialysis patients. Ren Fail 23:71-76, 2001
107. Renke M, Zegrzda D, Liberek T, Dudziak M, Lichodziejewska-Niemierko M, Kubasik A, Rutkowski B: Interrelationship between cardiac structure and function and incidence of arrhythmia in peritoneal dialysis patients. Int J Artif Organs 24:374-379, 2001
108. Collins AJ, Li S, Ma JZ, Herzog C: Cardiovascular disease in end-stage renal disease patients. Am J Kidney Dis 38:S26-29, 2001 (suppl 1)
109. Coresh J, Longenecker JC, Miller ER, Young 3rd, HJ, Klag MJ: Epidemiology of cardiovascular risk factors in chronic renal disease. J Am Soc Nephrol 9:S24-30, 1998
110. Foley RN, Parfrey PS, Sarnak MJ: Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 9:S16-23, 1998
111. Foley RN, Parfrey PS, Harnett JD, Kent GM, Hu L, O’Dea R, Murray DC, Barre PE: Hypocalcemia, morbidity, and mortality in end-stage renal disease. Am J Nephrol 16:386-393, 1996
112. Saran R, Bragg-Gresham JL, Rayner HC, Goodkin DA, Keen ML, Van Dijk PC, Kurokawa K, Piera L, Saito A, Fukuhara S, Young EW, Held PJ, Port FK: Nonadherence in hemodialysis: associations with mortality, hospitalization, and practice patterns in the DOPPS. Kidney Int 64:254-262, 2003
113. Goodkin DA, Mapes DL, Held PJ: The dialysis outcomes and practice patterns study (DOPPS): how can we improve the care of hemodialysis patients? Semin Dial 14:157-159, 2001
114. Goodkin DA, Bragg-Gresham JL, Koenig KG, Wolfe RA, Akiba T, Andreucci VE, Saito A, Rayner HC, Kurokawa K, Port FK, Held PJ, Young EW: Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol 14:3270-3277, 2003
115. Hecking E, Bragg-Gresham JL, Rayner HC, Pisoni RL, Andreucci VE, Combe C, Greenwood R, McCullough K, Feldman HI, Young EW, Held PJ, Port FK: Haemodialysis prescription, adherence and nutritional indicators in five European countries: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 19:100-107, 2004
116. Abbott KC, Trespalacios FC, Taylor AJ, Agodoa LY: Atrial fibrillation in chronic dialysis patients in the United States: risk factors for hospitalization and mortality. BMC Nephrol 4:1, 2003
117. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877-883, 2002
118. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G: A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 341:1882-1890, 1999
119. Buxton AE: The clinical use of implantable cardioverter defibrillators: where are we now? Where should we go? Ann Intern Med 138:512-514, 2003
120. Cairns JA, Connolly SJ, Roberts R, Gent M: Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Lancet 349:675-682, 1997
121. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH: Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350:2151-2158, 2004
122. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM: Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350:2140-2150, 2004
123. Josephson ME, Callans DJ, Buxton AE: The role of the implantable cardioverter-defibrillator for prevention of sudden cardiac death. Ann Intern Med 133:901-910, 2000
124. Kennedy HL: Beta blockade, ventricular arrhythmias, and sudden cardiac death. Am J Cardiol 80:29J-34J, 1997
125. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 337:1576-1583, 1997
126. Bocker D, Block M, Isbruch F, Fastenrath C, Castrucci M, Hammel D, Scheld HH, Borggrefe M, Breithardt G: Benefits of treatment with implantable cardioverter-defibrillators in patients with stable ventricular tachycardia without cardiac arrest. Br Heart J 73:158-163, 1995
127. Janse MJ: A brief history of sudden cardiac death and its therapy. Pharmacol Ther 100:89-99, 2003
128. Poole-Wilson PA, Swedberg K, Cleland JG, Di Lenarda A, Hanrath P, Komajda M, Lubsen J, Lutiger B, Metra M, Remme WJ, Torp-Pedersen C, Scherhag A, Skene A: Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet 362:7-13, 2003
129. Christensen JH, Gustenhoff P, Korup E, Aaroe J, Toft E, Moller J, Rasmussen K, Dyerberg J, Schmidt EB: Effect of fish oil on heart rate variability in survivors of myocardial infarction: a double blind randomised controlled trial. Brit Med J 312:677-678, 1996
130. Foley RN, Herzog CA, Collins AJ: Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study. Kidney Int 62:1784-1790, 2002
131. Zuanetti G, Maggioni AP, Keane W, Ritz E: Nephrologists neglect administration of betablockers to dialysed diabetic patients. Nephrol Dial Transplant 12:2497-2500, 1997
132. Huynh-Do U, Wahl C, Sulzer M, Buhler H, Keusch G: Torsades de pointes during low-dosage sotalol therapy in haemodialysis patients. Nephrol Dial Transplant 11:1153-1154, 1996
133. Rizza C, Valderrabano M, Singh BN: Recurrent Torsades de Pointes After Sotalol Therapy for Symptomatic Paroxysmal Atrial Fibrillation in a Patient with End-Stage Renal Disease. J Cardiovasc Pharmacol Ther 4:129-134, 1999
134. Donnan GA, Dewey HM, Chambers BR: Warfarin for atrial fibrillation: the end of an era? Lancet Neurol 3:305-308, 2004
135. Halperin JL: Ximelagatran compared with warfarin for prevention of thromboembolism in patients with nonvalvular atrial fibrillation: Rationale, objectives, and design of a pair of clinical studies and baseline patient characteristics (SPORTIF III and V). Am Heart J 146:431-438, 2003
136. Olsson SB: Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial. Lancet 362:1691-1698, 2003
137. Becker L, Eisenberg M, Fahrenbruch C, Cobb L: Cardiac arrest in medical and dental practices: implications for automated external defibrillators. Arch Intern Med 161:1509-1512, 2001
138. Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Part 10: pediatric advanced life support. The American Heart Association in collaboration with the International Liaison Committee on Resuscitation. Circulation 102:I291-342, 2000
139. Seliger SL, Gillen DL, Longstreth WTJ, Kestenbaum B, Stehman-Breen CO: Elevated risk of stroke among patients with end-stage renal disease. Kidney Int 64:603-609, 2003
140. Kawamura M, Fijimoto S, Hisanaga S, Yamamoto Y, Eto T: Incidence, outcome, and risk factors of cerebrovascular events in patients undergoing maintenance hemodialysis. Am J Kidney Dis 31:991-996, 1998
141. Iseki K, Fukiyama K: Predictors of stroke in patients receiving chronic hemodialysis. Kidney Int 50:1672-1675, 1996
142. Pascazio L, Bianco F, Giorgini A, Galli G, Curri G, Panzetta G: Echo color Doppler imaging of carotid vessels in hemodialysis patients: evidence of high levels of atherosclerotic lesions. Am J Kidney Dis 28:713-720, 1996
143. Benedetto FA, Mallamaci F, Tripepi G, Zoccali C: Prognostic value of ultrasonographic measurement of carotid intima media thickness in dialysis patients. J Am Soc Nephrol 12:2458-2464, 2001
144. Eggers PW, Gohdes D, Pugh J: Nontraumatic lower extremity amputations in the Medicare end-stage renal disease population. Kidney Int 56:1524-1533, 1999
145. O’Hare AM, Bacchetti P, Segal M, Hsu CY, Johansen KL: Factors associated with future amputation among patients undergoing hemodialysis: results from the Dialysis Morbidity and Mortality Study Waves 3 and 4. Am J Kidney Dis 41:162-170, 2003
146. Leskinen Y, Salenius JP, Lehtimaki T, Huhtala H, Saha H: The prevalence of peripheral arterial disease and medial arterial calcification in patients with chronic renal failure: requirements for diagnostics. Am J Kidney Dis 40:472-479, 2002
147. Fishbane S, Youn S, Flaster E, Adam G, Maesaka JK: Ankle-arm blood pressure index as a predictor of mortality in hemodialysis patients. Am J Kidney Dis 27:668-672, 1996
148. Ono K, Tsuchida A, Kawai H, Matsuo H, Wakamatsu R, Maezawa A, Yano S, Kawada T, Nojima Y: Ankle-brachial blood pressure index predicts all-cause and cardiovascular mortality in hemodialysis patients. J Am Soc Nephrol 14:1591-1598, 2003
149. Hiatt WR: Medical treatment of peripheral arterial disease and claudication. N Engl J Med 344:1608-1621, 2001
150. Reddan DN, Marcus RJ, Owen WF, Jr., Szczech LA, Landwehr DM: Long-term outcomes of revascularization for peripheral vascular disease in end-stage renal disease patients. Am J Kidney Dis 38:57-63, 2001
151. Dossa CD, Shepard AD, Amos AM, Kupin WL, Reddy DJ, Elliott JP, Wilczwski JM, Ernst CB: Results of lower extremity amputations in patients with end-stage renal disease. J Vasc Surg 20:14-19, 1994
152. Korn P, Hoenig SJ, Skillman JJ, Kent KC: Is lower extremity revascularization worthwhile in patients with end-stage renal disease? Surgery 128:472-479, 2000
153. Johnson BL, Glickman MH, Bandyk DF, Esses GE: Failure of foot salvage in patients with end-stage renal disease after surgical revascularization. J Vasc Surg 22:280-285; discussion 285-286, 1995
154. O’Hare AM, Feinglass J, Sidawy AN, Bacchetti P, Rodriguez RA, Daley J, Khuri S, Henderson WG, Johansen KL: Impact of renal insufficiency on short-term morbidity and mortality after lower extremity revascularization: data from the Department of Veterans Affairs’ National Surgical Quality Improvement Program. J Am Soc Nephrol 14:1287-1295, 2003
155. Sakurai T, Kobayashi M, Harasawa H, Itoh A, Yamazaki C, Masuko K: Infrainguinal arterial reconstruction in end-stage renal disease. Cardiovasc Surg 3:46-49, 1995
156. Lumsden AB, Besman A, Jaffe M, MacDonald MJ, Allen RC: Infrainguinal revascularization in end-stage renal disease. Ann Vasc Surg 8:107-112, 1994
157. Simsir SA, Cabellon A, Kohlman-Trigoboff D, Smith BM: Factors influencing limb salvage and survival after amputation and revascularization in patients with end-stage renal disease. Am J Surg 170:113-117, 1995
158. Baele HR, Piotrowski JJ, Yuhas J, Anderson C, Alexander JJ: Infrainguinal bypass in patients with end-stage renal disease. Surgery 117:319-324, 1995
159. Oishi K, Nagake Y, Yamasaki H, Fukuda S, Ichikawa H, Ota K, Makino H: The significance of atherogenic indices in patients on hemodialysis. Am J Nephrol 20:107-115, 2000
160. Franz MJ, Bantle JP, Beebe CA, Brunzell JD, Chiasson JL, Garg A, Holzmeister LA, Hoogwerf B, Mayer-Davis E, Mooradian AD, Purnell JQ, Wheeler M: Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care 26:S51-61, 2003 (suppl 1)
161. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 329:977-986, 1993
162. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. N Engl J Med 342:381-389, 2000
163. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352:837-853, 1998
164. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352:854-865, 1998
165. Joy MS, Cefalu WT, Hogan SL, Nachman PH: Long-term glycemic control measurements in diabetic patients receiving hemodialysis. Am J Kidney Dis 39:297-307, 2002
166. Oyibo SO, Pritchard GM, McLay L, James E, Laing I, Gokal R, Boulton AJ: Blood glucose overestimation in diabetic patients on continuous ambulatory peritoneal dialysis for end-stage renal disease. Diabet Med 19:693-696, 2002
167. Tzamaloukas AH: Interpreting glycosylated hemoglobin in diabetic patients on peritoneal dialysis. Adv Perit Dial 12:171-175, 1996
168. Franz MJ, Bantle JP, Beebe CA, Brunzell JD, Chiasson JL, Garg A, Holzmeister LA, Hoogwerf B, Mayer-Davis E, Mooradian AD, Purnell JQ, Wheeler M: Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care 25:148-198, 2002
169. Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI, National Kidney Foundation. Am J Kidney Dis 35:S1-140, 2000 (suppl 2)
170. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr., Jones DW, Materson BJ, Oparil S, Wright JT, Jr., Roccella EJ: Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42:1206-1252, 2003
171. Lameire N, Van Biesen W: Importance of blood pressure and volume control in peritoneal dialysis patients. Perit Dial Int 21:206-211, 2001
172. Medcalf JF, Harris KP, Walls J: Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis. Kidney Int 59:1128-1133, 2001
173. Stegmayr BG: Beta-blockers may cause ultrafiltration failure in peritoneal dialysis patients. Perit Dial Int 17:541-545, 1997
174. Stegmayr BG: Beta-blocker use in peritoneal dialysis patients. Semin Dial 14:73, 2001
175. Agarwal R, Nissenson AR, Batlle D, Coyne DW, Trout JR, Warnock DG: Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. Am J Med 115:291-297, 2003
176. Ritz E, Koch M: Morbidity and mortality due to hypertension in patients with renal failure. Am J Kidney Dis 21:113-118, 1993
177. Foley RN, Parfrey PS: Cardiovascular disease and mortality in ESRD. J Nephrol 11:239-245, 1998
178. Zager PG, Nikolic J, Brown RH, Campbell MA, Hunt WC, Peterson D, Van Stone J, Levey A, Meyer KB, Klag MJ, Johnson HK, Clark E, Sadler JH, Teredesai P: “U” curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc. Kidney Int 54:561-569, 1998
179. Duranti E, Imperiali P, Sasdelli M: Is hypertension a mortality risk factor in dialysis? Kidney Int Suppl 55:S173-174, 1996
180. U.S. Renal Data System: USRDS 1998 Annual Data Report, in, Bethesda, The National Institutes of Health, National Institute of Diabetes and Digestive Diseases, 1998
181. Lowrie EG, Lew NL: Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 15:458-482, 1990
182. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int 49:1379-1385, 1996
183. Dart AM, Kingwell BA: Pulse pressure–a review of mechanisms and clinical relevance. J Am Coll Cardiol 37:975-984, 2001
184. Boutouyrie P, Bussy C, Lacolley P, Girerd X, Laloux B, Laurent S: Association between local pulse pressure, mean blood pressure, and large-artery remodeling. Circulation 100:1387-1393, 1999
185. James MA, Watt PA, Potter JF, Thurston H, Swales JD: Pulse pressure and resistance artery structure in the elderly. Hypertension 26:301-306, 1995
186. Kozakova M, Morizzo C, Ferrannini E, Palombo C: Coronary vasodilator capacity and exercise-induced myocardial ischemia are related to the pulsatile component of blood pressure in patients with essential hypertension. J Hypertens 21:1407-1414, 2003
187. Christensen KL: Reducing pulse pressure in hypertension may normalize small artery structure. Hypertension 18:722-727, 1991
188. Tozawa M, Iseki K, Iseki C, Takishita S: Pulse pressure and risk of total mortality and cardiovascular events in patients on chronic hemodialysis. Kidney Int 61:717-726, 2002
189. Blacher J, Asmar R, Djane S, London GM, Safar ME: Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 33:1111-1117, 1999
190. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM: Impact of aortic stiffness on survival in end-stage renal disease. Circulation 99:2434-2439, 1999
191. Avolio AP, Chen SG, Wang RP, Zhang CL, Li MF, O’Rourke MF: Effects of aging on changing arterial compliance and left ventricular load in a northern Chinese urban community. Circulation 68:50-58, 1983
192. Safar ME, Blacher J, Pannier B, Guerin AP, Marchais SJ, Guyonvarc’h PM, London GM: Central pulse pressure and mortality in end-stage renal disease. Hypertension 39:735-738, 2002
193. Asmar RG, Pannier B, Santoni JP, Laurent S, London GM, Levy BI, Safar ME: Reversion of cardiac hypertrophy and reduced arterial compliance after converting enzyme inhibition in essential hypertension. Circulation 78:941-950, 1988
194. London GM, Marchais SJ, Guerin AP, Metivier F, Safar ME, Fabiani F, Froment L: Salt and water retention and calcium blockade in uremia. Circulation 82:105-113, 1990
195. Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM: Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 103:987-992, 2001
196. Perloff D, Grim C, Flack J, Frohlich ED, Hill M, McDonald M, Morgenstern BZ: Human blood pressure determination by sphygmomanometry. Circulation 88:2460-2470, 1993
197. Gerin W, Schwartz AR, Schwartz JE, Pickering TG, Davidson KW, Bress J, O’Brien E, Atkins N: Limitations of current validation protocols for home blood pressure monitors for individual patients. Blood Press Monit 7:313-318, 2002
198. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr., Jones DW, Materson BJ, Oparil S, Wright JT, Jr., Roccella EJ: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289:2560-2572, 2003
199. Rahman M, Griffin V, Kumar A, Manzoor F, Wright JT, Jr., Smith MC: A comparison of standardized versus “usual” blood pressure measurements in hemodialysis patients. Am J Kidney Dis 39:1226-1230, 2002
200. Conion PJ, Walshe JJ, Heinle SK, Minda S, Krucoff M, Schwab SJ: Predialysis systolic blood pressure correlates strongly with mean 24-hour systolic blood pressure and left ventricular mass in stable hemodialysis patients. J Am Soc Nephrol 7:2658-2663, 1996
201. Kooman JP, Gladziwa U, Bocker G, Wijnen JA, Bortel L, Luik AJ, de Leeuw PW, van Hoff JP, Leunissen KM: Blood pressure during the interdialytic period in haemodialysis patients: estimation of representative blood pressure values. Nephrol Dial Transplant 7:917-923, 1992
202. Coomer RW, Schulman G, Breyer JA, Shyr Y: Ambulatory blood pressure monitoring in dialysis patients and estimation of mean interdialytic blood pressure. Am J Kidney Dis 29:678-684, 1997
203. Agarwal R, Lewis RR: Prediction of hypertension in chronic hemodialysis patients. Kidney Int 60:1982-1989, 2001
204. Millar-Craig MW, Bishop CN, Raftery EB: Circadian variation of blood-pressure. Lancet 1:795-797, 1978
205. National High Blood Pressure Education Program Working Group report on ambulatory blood pressure monitoring. Arch Intern Med 150:2270-2280, 1990
206. Mancia G, Ferrari A, Gregorini L, Parati G, Pomidossi G, Bertinieri G, Grassi G, di Rienzo M, Pedotti A, Zanchetti A: Blood pressure and heart rate variabilities in normotensive and hypertensive human beings. Circ Res 53:96-104, 1983
207. Shimada K, Kawamoto A, Matsubayashi K, Nishinaga M, Kimura S, Ozawa T: Diurnal blood pressure variations and silent cerebrovascular damage in elderly patients with hypertension. J Hypertens 10:875-878, 1992
208. O’Brien E, Sheridan J, O’Malley K: Dippers and non-dippers. Lancet 2:397, 1988
209. Verdecchia P, Schillaci G, Guerrieri M, Gatteschi C, Benemio G, Boldrini F, Porcellati C: Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 81:528-536, 1990
210. Farmer CK, Goldsmith DJ, Cox J, Dallyn P, Kingswood JC, Sharpstone P: An investigation of the effect of advancing uraemia, renal replacement therapy and renal transplantation on blood pressure diurnal variability. Nephrol Dial Transplant 12:2301-2307, 1997
211. Baumgart P, Walger P, Gemen S, von Eiff M, Raidt H, Rahn KH: Blood pressure elevation during the night in chronic renal failure, hemodialysis and after renal transplantation. Nephron 57:293-298, 1991
212. Peixoto AJ, White WB: Ambulatory blood pressure monitoring in chronic renal disease: technical aspects and clinical relevance. Curr Opin Nephrol Hypertens 11:507-516, 2002
213. Ritz E, Schwenger V, Zeier M, Rychlik I: Ambulatory blood pressure monitoring: fancy gadgetry or clinically useful exercise? Nephrol Dial Transplant 16:1550-1554, 2001
214. Santos SF, Mendes RB, Santos CA, Dorigo D, Peixoto AJ: Profile of interdialytic blood pressure in hemodialysis patients. Am J Nephrol 23:96-105, 2003
215. Sokolow M, Werdegar D, Kain HK, Hinman AT: Relationship between level of blood pressure measured casually and by portable recorders and severity of complications in essential hypertension. Circulation 34:279-298, 1966
216. Agarwal R: Role of home blood pressure monitoring in hemodialysis patients. Am J Kidney Dis 33:682-687, 1999
217. Perin PC, Maule S, Quadri R: Sympathetic nervous system, diabetes, and hypertension. Clin Exp Hypertens 23:45-55, 2001
218. O’Shea JC, Murphy MB: Nocturnal blood pressure dipping: a consequence of diurnal physical activity blipping? Am J Hypertens 13:601-606, 2000
219. Hanly PJ, Pierratos A: Improvement of sleep apnea in patients with chronic renal failure who undergo nocturnal hemodialysis. N Engl J Med 344:102-107, 2001
220. Zoccali C, Benedetto FA, Tripepi G, Cambareri F, Panuccio V, Candela V, Mallamaci F, Enia G, Labate C, Tassone F: Nocturnal hypoxemia, night-day arterial pressure changes and left ventricular geometry in dialysis patients. Kidney Int 53:1078-1084, 1998
221. Sorof JM, Brewer ED, Portman RJ: Ambulatory blood pressure monitoring and interdialytic weight gain in children receiving chronic hemodialysis. Am J Kidney Dis 33:667-674, 1999
222. Uzu T, Ishikawa K, Fujii T, Nakamura S, Inenaga T, Kimura G: Sodium restriction shifts circadian rhythm of blood pressure from nondipper to dipper in essential hypertension. Circulation 96:1859-1862, 1997
223. Higashi Y, Oshima T, Ozono R, Nakano Y, Matsuura H, Kambe M, Kajiyama G: Nocturnal decline in blood pressure is attenuated by NaCl loading in salt-sensitive patients with essential hypertension: noninvasive 24-hour ambulatory blood pressure monitoring. Hypertension 30:163-167, 1997
224. Toth L, Voros P, Lengyel Z, Liptai M, Nemeth C, Kammerer L: Diurnal blood pressure variations in incipient and end stage diabetic renal disease. Diabetes Res Clin Pract 49:1-6, 2000
225. McGregor DO, Buttimore AL, Nicholls MG, Lynn KL: Ambulatory blood pressure monitoring in patients receiving long, slow home haemodialysis. Nephrol Dial Transplant 14:2676-2679, 1999
226. Fagugli RM, Reboldi G, Quintaliani G, Pasini P, Ciao G, Cicconi B, Pasticci F, Kaufman JM, Buoncristiani U: Short daily hemodialysis: blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients. Am J Kidney Dis 38:371-376, 2001
227. Perloff D, Sokolow M, Cowan R: The prognostic value of ambulatory blood pressures. JAMA 249:2792-2798, 1983
228. Devereux RB, Pickering TG, Harshfield GA, Kleinert HD, Denby L, Clark L, Pregibon D, Jason M, Kleiner B, Borer JS, Laragh JH: Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regularly recurring stress. Circulation 68:470-476, 1983
229. White WB, Schulman P, McCabe EJ, Dey HM: Average daily blood pressure, not office blood pressure, determines cardiac function in patients with hypertension. JAMA 261:873-877, 1989
230. Parati G, Pomidossi G, Albini F, Malaspina D, Mancia G: Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens 5:93-98, 1987
231. Shimada K, Kawamoto A, Matsubayashi K, Ozawa T: Silent cerebrovascular disease in the elderly. Correlation with ambulatory pressure. Hypertension 16:692-699, 1990
232. Peixoto AJ, Santos SF, Mendes RB, Crowley ST, Maldonado R, Orias M, Mansoor GA, White WB: Reproducibility of ambulatory blood pressure monitoring in hemodialysis patients. Am J Kidney Dis 36:983-990, 2000
233. Amar J, Vernier I, Rossignol E, Bongard V, Arnaud C, Conte JJ, Salvador M, Chamontin B: Nocturnal blood pressure and 24-hour pulse pressure are potent indicators of mortality in hemodialysis patients. Kidney Int 57:2485-2491, 2000
234. Omboni S, Parati G, Palatini P, Vanasia A, Muiesan ML, Cuspidi C, Mancia G: Reproducibility and clinical value of nocturnal hypotension: prospective evidence from the SAMPLE study. Study on Ambulatory Monitoring of Pressure and Lisinopril Evaluation. J Hypertens 16:733-738, 1998
235. Horl MP, Horl WH: Hemodialysis-associated hypertension: pathophysiology and therapy. Am J Kidney Dis 39:227-244, 2002
236. Leypoldt JK, Cheung AK, Delmez JA, Gassman JJ, Levin NW, Lewis JA, Lewis JL, Rocco MV: Relationship between volume status and blood pressure during chronic hemodialysis. Kidney Int 61:266-275, 2002
237. Chazot C, Charra B, Laurent G, Didier C, Vo Van C, Terrat JC, Calemard E, Vanel T, Ruffet M: Interdialysis blood pressure control by long haemodialysis sessions. Nephrol Dial Transplant 10:831-837, 1995
238. Katzarski KS, Charra B, Luik AJ, Nisell J, Divino Filho JC, Leypoldt JK, Leunissen KM, Laurent G, Bergstrom J: Fluid state and blood pressure control in patients treated with long and short haemodialysis. Nephrol Dial Transplant 14:369-375, 1999
239. Charra B, Calemard E, Ruffet M, Chazot C, Terrat JC, Vanel T, Laurent G: Survival as an index of adequacy of dialysis. Kidney Int 41:1286-1291, 1992
240. Ozkahya M, Toz H, Unsal A, Ozerkan F, Asci G, Gurgun C, Akcicek F, Mees EJ: Treatment of hypertension in dialysis patients by ultrafiltration: role of cardiac dilatation and time factor. Am J Kidney Dis 34:218-221, 1999
241. Kooistra MP, Vos J, Koomans HA, Vos PF: Daily home haemodialysis in The Netherlands: effects on metabolic control, haemodynamics, and quality of life. Nephrol Dial Transplant 13:2853-2860, 1998
242. Traeger J, Sibai-Galland R, Delawari E, Arkouche W: Daily versus standard hemodialysis: one year experience. Artif Organs 22:558-563, 1998
243. Nesrallah G, Suri R, Moist L, Kortas C, Lindsay RM: Volume control and blood pressure management in patients undergoing quotidian hemodialysis. Am J Kidney Dis 42:13-17, 2003
244. Chan CT, Floras JS, Miller JA, Richardson RM, Pierratos A: Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int 61:2235-2239, 2002
245. Schalekamp MA, Schalekamp-Kuyken MP, de Moor-Fruytier M, Meininger T, Vaandrager-Kranenburg DJ, Birkenhager WH: Interrelationships between blood pressure, renin, renin substrate and blood volume in terminal renal failure. Clin Sci Mol Med 45:417-428, 1973
246. Schultze G, Piefke S, Molzahn M: Blood pressure in terminal renal failure. Fluid spaces and the renin-angiotensin-system. Nephron 25:15-24, 1980
247. Chan MK, Baillod RA, Chuah P, Sweny P, Raftery MJ, Varghese Z, Moorhead JF: Three years’ experience of continuous ambulatory peritoneal dialysis. Lancet 1:1409-1412, 1981
248. Saldanha LF, Weiler EW, Gonick HC: Effect of continuous ambulatory peritoneal dialysis on blood pressure control. Am J Kidney Dis 21:184-188, 1993
249. Eschbach JW, Kelly MR, Haley NR, Abels RI, Adamson JW: Treatment of the anemia of progressive renal failure with recombinant human erythropoietin. N Engl J Med 321:158-163, 1989
250. Eschbach JW, Abdulhadi MH, Browne JK, Delano BG, Downing MR, Egrie JC, Evans RW, Friedman EA, Graber SE, Haley NR: Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial. Ann Intern Med 111:992-1000, 1989
251. Adamson JW, Eschbach JW: Treatment of the anemia of chronic renal failure with recombinant human erythropoietin. Annu Rev Med 41:349-360, 1990
252. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, Menard J, Rahn KH, Wedel H, Westerling S: Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 351:1755-1762, 1998
253. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G: The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 330:877-884, 1994
254. Agodoa LY, Appel L, Bakris GL, Beck G, Bourgoignie J, Briggs JP, Charleston J, Cheek D, Cleveland W, Douglas JG, Douglas M, Dowie D, Faulkner M, Gabriel A, Gassman J, Greene T, Hall Y, Hebert L, Hiremath L, Jamerson K, Johnson CJ, Kopple J, Kusek J, Lash J, Lea J, Lewis JB, Lipkowitz M, Massry S, Middleton J, Miller ER, 3rd, Norris K, O’Connor D, Ojo A, Phillips RA, Pogue V, Rahman M, Randall OS, Rostand S, Schulman G, Smith W, Thornley-Brown D, Tisher CC, Toto RD, Wright JT, Jr., Xu S: Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. JAMA 285:2719-2728, 2001
255. 1995 update of the working group reports on chronic renal failure and renovascular hypertension. National High Blood Pressure Education Program Working Group. Arch Intern Med 156:1938-1947, 1996
256. Cannella G, Paoletti E, Delfino R, Peloso G, Rolla D, Molinari S: Prolonged therapy with ACE inhibitors induces a regression of left ventricular hypertrophy of dialyzed uremic patients independently from hypotensive effects. Am J Kidney Dis 30:659-664, 1997
257. Paoletti E, Cassottana P, Bellino D, Specchia C, Messa P, Cannella G: Left ventricular geometry and adverse cardiovascular events in chronic hemodialysis patients on prolonged therapy with ACE inhibitors. Am J Kidney Dis 40:728-736, 2002
258. Shibasaki Y, Masaki H, Nishiue T, Nishikawa M, Matsubara H, Iwasaka T: Angiotensin II type 1 receptor antagonist, losartan, causes regression of left ventricular hypertrophy in end-stage renal disease. Nephron 90:256-261, 2002
259. Efrati S, Zaidenstein R, Dishy V, Beberashvili I, Sharist M, Averbukh Z, Golik A, Weissgarten J: ACE inhibitors and survival of hemodialysis patients. Am J Kidney Dis 40:1023-1029, 2002
260. Kestenbaum B, Gillen DL, Sherrard DJ, Seliger S, Ball A, Stehman-Breen C: Calcium channel blocker use and mortality among patients with end-stage renal disease. Kidney Int 61:2157-2164, 2002
261. Cirit M, Akcicek F, Terzioglu E, Soydas C, Ok E, Ozbasli CF, Basci A, Mees EJ: ‘Paradoxical’ rise in blood pressure during ultrafiltration in dialysis patients. Nephrol Dial Transplant 10:1417-1420, 1995
262. Liu Y, Coresh J, Eustace JA, Longenecker JC, Jaar B, Fink NE, Tracy RP, Powe NR, Klag MJ: Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition. JAMA 291:451-459, 2004
263. Holdaas H, Fellstrom B, Jardine AG, Holme I, Nyberg G, Fauchald P, Gronhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambuhl P, Olsson AG, Hartmann A, Solbu DO, Pedersen TR: Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial. Lancet 361:2024-2031, 2003
264. Sever PS, Dahlof B, Poulter NR, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O’Brien E, Ostergren J: Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial–Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 361:1149-1158, 2003
265. Tonelli M, Moye L, Sacks FM, Kiberd B, Curhan G: Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency. Ann Intern Med 138:98-104, 2003
266. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360:7-22, 2002
267. Wanner C, Krane V, Marz W, Olschewski M, Asmus HG, Kramer W, Kuhn KW, Kutemeyer H, Mann JF, Ruf G, Ritz E: Randomized controlled trial on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D study): demographic and baseline characteristics. Kidney Blood Press Res 27:259-266, 2004
268. Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, Thomason MJ, Mackness MI, Charlton-Menys V, Fuller JH: Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 364:685-696, 2004
269. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486-2497, 2001
270. Rozanski A, Blumenthal JA, Kaplan J: Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 99:2192-2217, 1999
271. Hensie LE, Campbell RJ: Psychiatric Dictionary, Oxford University Press, 1970
272. Blair SN, Kohl HW, 3rd, Paffenbarger RS, Jr., Clark DG, Cooper KH, Gibbons LW: Physical fitness and all-cause mortality. A prospective study of healthy men and women. JAMA 262:2395-2401, 1989
273. Wei M, Gibbons LW, Mitchell TL, Kampert JB, Lee CD, Blair SN: The association between cardiorespiratory fitness and impaired fasting glucose and type 2 diabetes mellitus in men. Ann Intern Med 130:89-96, 1999
274. Wei M, Gibbons LW, Kampert JB, Nichaman MZ, Blair SN: Low cardiorespiratory fitness and physical inactivity as predictors of mortality in men with type 2 diabetes. Ann Intern Med 132:605-611, 2000
275. Blair SN, Goodyear NN, Gibbons LW, Cooper KH: Physical fitness and incidence of hypertension in healthy normotensive men and women. JAMA 252:487-490, 1984
276. Office of the U.S. Surgeon General, Physical Activity and Health: A Report of the Surgeon General, in, U.S. Department of Health and Human Services, Public Health Service, 1996
277. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. National Heart, Lung and Blood Institute: Bethesda. Bethesda, MD, NHLBI, 1997
278. National Cholesterol Education Project, Third Report of the Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adult (Adult Treatment Panel III), in, Bethesda, MD, NIH - NHLBI, 2000
279. DeOreo PB: Hemodialysis patient-assessed functional health status predicts continued survival, hospitalization, and dialysis-attendance compliance. Am J Kidney Dis 30:204-212, 1997
280. Sietsema KE, Amato A, Adler SG, Brass EP: Exercise capacity as a predictor of survival among ambulatory patients with end-stage renal disease. Kidney Int 65:719-724, 2004
281. Goldberg AP, Hagberg JM, Delmez JA, Heath GW, Harter HR: Exercise training improves abnormal lipid and carbohydrate metabolism in hemodialysis patients. Trans Am Soc Artif Intern Organs 25:431-437, 1979
282. Goldberg AP, Geltman EM, Hagberg JM, Gavin JR, Delmez 3rd, JA, Carney RM, Naumowicz A, Oldfield MH, Harter HR: Therapeutic benefits of exercise training for hemodialysis patients. Kidney Int Suppl 16:S303-309, 1983
283. Goldberg AP, Geltman EM, Gavin JR, Carney 3rd, RM, Hagberg JM, Delmez JA, Naumovich A, Oldfield MH, Harter HR: Exercise training reduces coronary risk and effectively rehabilitates hemodialysis patients. Nephron 42:311-316, 1986
284. Deligiannis A, Kouidi E, Tassoulas E, Gigis P, Tourkantonis A, Coats A: Cardiac effects of exercise rehabilitation in hemodialysis patients. Int J Cardiol 70:253-266, 1999
285. Deligiannis A, Kouidi E, Tourkantonis A: Effects of physical training on heart rate variability in patients on hemodialysis. Am J Cardiol 84:197-202, 1999
286. Hagberg JM, Goldberg AP, Ehsani AA, Heath GW, Delmez JA, Harter HR: Exercise training improves hypertension in hemodialysis patients. Am J Nephrol 3:209-212, 1983
287. Johansen KL, Chertow GM, Ng AV, Mulligan K, Carey S, Schoenfeld PY, Kent-Braun JA: Physical activity levels in patients on hemodialysis and healthy sedentary controls. Kidney Int 57:2564-2570, 2000
288. Johansen KL, Kaysen GA, Young BS, Hung AM, da Silva M, Chertow GM: Longitudinal study of nutritional status, body composition, and physical function in hemodialysis patients. Am J Clin Nutr 77:842-846, 2003
289. Kouidi E, Albani M, Natsis K, Megalopoulos A, Gigis P, Guiba-Tziampiri O, Tourkantonis A, Deligiannis A: The effects of exercise training on muscle atrophy in haemodialysis patients. Nephrol Dial Transplant 13:685-699, 1998
290. Lo CY, Li L, Lo WK, Chan ML, So E, Tang S, Yuen MC, Cheng IK, Chan TM: Benefits of exercise training in patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 32:1011-1018, 1998
291. Moore GE, Parsons DB, Stray-Gundersen J, Painter PL, Brinker KR, Mitchell JH: Uremic myopathy limits aerobic capacity in hemodialysis patients. Am J Kidney Dis 22:277-287, 1993
292. Painter PL, Nelson-Worel JN, Hill MM, Thornbery DR, Shelp WR, Harrington AR, Weinstein AB: Effects of exercise training during hemodialysis. Nephron 43:87-92, 1986
293. Painter P, Carlson L, Carey S, Paul SM, Myll J: Physical functioning and health-related quality-of-life changes with exercise training in hemodialysis patients. Am J Kidney Dis 35:482-492, 2000
294. Painter P, Moore G, Carlson L, Paul S, Myll J, Phillips W, Haskell W: Effects of exercise training plus normalization of hematocrit on exercise capacity and health-related quality of life. Am J Kidney Dis 39:257-265, 2002
295. Shalom R, Blumenthal JA, Williams RS, McMurray RG, Dennis VW: Feasibility and benefits of exercise training in patients on maintenance dialysis. Kidney Int 25:958-963, 1984
296. Zabetakis PM, Gleim GW, Pasternack FL, Saraniti A, Nicholas JA, Michelis MF: Long-duration submaximal exercise conditioning in hemodialysis patients. Clin Nephrol 18:17-22, 1982
297. Akiba T, Matsui N, Shinohara S, Fujiwara H, Nomura T, Marumo F: Effects of recombinant human erythropoietin and exercise training on exercise capacity in hemodialysis patients. Artif Organs 19:1262-1268, 1995
298. Goldstein MG, Niaura R: Psychological factors affecting physical condition. Cardiovascular disease literature review. Part I: Coronary artery disease and sudden death. Psychosomatics 33:134-145, 1992
299. Booth-Kewley S, Friedman HS: Psychological predictors of heart disease: a quantitative review. Psychological Bulletin 101:343-362, 1987
300. Todaro JF, Shen BJ, Niaura R, Spiro A, Ward KD: Effect of negative emotions on frequency of coronary heart disease (The Normative Aging Study). Am J Cardiol 92: 901-906, 2003
301. Musselman DL, Evans DL, Nemeroff CB: The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Pyschiat 55:580-592, 1998
302. Sirois BC, Burg MM: Negative emotion and coronary heart disease: A review. Behav Modif 27 83-102, 2003
303. Kimmel PL, Weihs K, Peterson RA: Survival in hemodialysis patients: the role of depression. J Am Soc Nephrol 4:12-27, 1993
304. Livesley WJ: Symptoms of anxiety and depression in patients undergoing chronic haemodialysis. J Psychosom Res 26:581-584, 1982
305. Kutner NG, Fair PL, Kutner MH: Assessing depression and anxiety in chronic dialysis patients. J Psychosom Res 29:23-31, 1985
306. Lopes AA, Albert JM, Young EW, Satayathum S, Pisoni RL, Andreucci VE, Mapes DL, Mason NA, Fukuhara S, Wikstrom B, Saito A, Port FK: Screening for depression in hemodialysis patients: associations with diagnosis, treatment, and outcomes in the DOPPS. Kidney Int 66:2047-2053, 2004
307. Medalie JH, Goldbourt U: Angina pectoris among 10,000 men. II. Psychosocial and other risk factors as evidenced by a multivariate analysis of a five year incidence study. Am J Med 60:910-921, 1976
308. Strik JJ, Denollet J, Lousberg R, Honig A: Comparing symptoms of depression and anxiety as predictors of cardiac events and increased health care consumption after myocardial infarction. J Am Coll Cardiol 42:1801-1807, 2003
309. Russek LG, King SH, Russek SJ, Russek HI: The Harvard Mastery of Stress Study 35-year follow-up: prognostic significance of patterns of psychophysiological arousal and adaptation. Psychosom Med 52:271-285, 1990
310. Verrier RL, Mittelman MA: Cardiovascular consequences of anger and other stress states. Baillieres Clinical Neurology 6:245-259, 1997
311. Suinn RM: The terrible twos–anger and anxiety. Hazardous to your health. Am Psychol 56:27-36, 2001
312. Fava M, Serafini E, De Besi L, Adami A, Mastrogiacomo, I.: Hyperprolactinemia and psychological distress in women undergoing chronic hemodialysis. Psychother Psychosom 49:6-9, 1988
313. White Y, Grenyer BF: The biopsychosocial impact of end-stage renal disease: the experience of dialysis patients and their partners. J Adv Nurs 30:1312-1320, 1999
314. Joynt KE, Whellan DJ, O’Connor CM: Depression and cardiovascular disease: mechanisms of interaction. Biol Psychiatry 54:248-261, 2003
315. Benedict RH, Fishman I, McClellan MM, Bakshi R, Weinstock-Guttman B: Validity of the Beck Depression Inventory-Fast Screen in multiple sclerosis. Mult Scler 9:393-396, 2003
316. Annotated Bibliography of the WHO Quality of Life Assessment Instrument–WHOQOL. Geneva, Switzerland, Department of Mental Health, WHO, 1998
317. Alarcon RD, Jenkins CS, Heestand DE, Scott LK, Cantor L: The effectiveness of progressive relaxation in chronic hemodialysis patients. J Chronic Dis 35:797-802, 1982
318. Mayne TJ, Ambrose TK: Research review on anger in psychotherapy. J Clin Psychol 55:353-363, 1999
319. Matthews KA, Haynes SG: Type A behavior pattern and coronary disease risk. Update and critical evaluation. Am J Epidemiol 123:923-960, 1986
320. Klang B, Bjorvell H, Berglund J, Sundstedt C, Clyne N: Predialysis patient education: effects on functioning and well-being in uraemic patients. J Adv Nurs 28:36-44, 1998
321. Kimmel PL: Depression as a mortality risk factor in hemodialysis patients. Int J Artif Organs 15:697-700, 1992
322. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C: Inflammation enhances cardiovascular risk and mortality in